menu search

AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients

AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its application for premarket approval (PMA) […] The post AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo... Read More
Posted: Jun 16 2023, 18:47
Author Name: forextv
Views: 112582

Search within

Pages Search Results: